
Dual-compound desire protocol · Kisspeptin-10 + PT-141
Two complementary compounds targeting hormonal and neurological desire pathways for comprehensive intimate wellness support.
HPG axis neuropeptide supporting gonadotropin release and hormonal drive in both men and women.
Central melanocortin receptor agonist supporting arousal and desire through a distinct neurological pathway.
The LIBIDO Protocol targets two complementary neurological and hormonal pathways associated with sexual desire and intimate wellness. Kisspeptin-10 operates at the hypothalamic level, supporting gonadotropin release and hormonal drive, while PT-141 acts via melanocortin receptors.
Kisspeptin-10 is a naturally occurring neuropeptide that plays a key role in regulating the HPG (Hypothalamic-Pituitary-Gonadal) axis — the central hormonal pathway governing sexual function and desire in both men and women.
PT-141 (Bremelanotide) works via central melanocortin receptors (MC3R and MC4R) — a distinct neurological pathway from hormonal approaches, offering complementary desire and arousal support. Together these two compounds address desire from both hormonal and neurological angles.
Every Lumeva protocol is manufactured using advanced synthesis techniques within controlled laboratory environments. Carries ≥99.9% purity certification and full batch-specific QA documentation.
Book a confidential consultation to ensure the LIBIDO Protocol is right for your intimate wellness goals.